155 related articles for article (PubMed ID: 2018160)
21. Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder.
Mokhber N; Azarpazhooh MR; Khajehdaluee M; Velayati A; Hopwood M
Psychiatry Clin Neurosci; 2010 Apr; 64(2):128-33. PubMed ID: 20132529
[TBL] [Abstract][Full Text] [Related]
22. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
23. Buspirone: multicenter efficacy study.
Wheatley D
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
[TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of the Cool Teens CD-ROM computerized program for adolescent anxiety.
Wuthrich VM; Rapee RM; Cunningham MJ; Lyneham HJ; Hudson JL; Schniering CA
J Am Acad Child Adolesc Psychiatry; 2012 Mar; 51(3):261-70. PubMed ID: 22365462
[TBL] [Abstract][Full Text] [Related]
25. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
Piskulić D; Olver JS; Maruff P; Norman TR
Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders.
Kabat-Zinn J; Massion AO; Kristeller J; Peterson LG; Fletcher KE; Pbert L; Lenderking WR; Santorelli SF
Am J Psychiatry; 1992 Jul; 149(7):936-43. PubMed ID: 1609875
[TBL] [Abstract][Full Text] [Related]
27. Treating individuals with debilitating performance anxiety: An introduction.
Powell DH
J Clin Psychol; 2004 Aug; 60(8):801-8. PubMed ID: 15241808
[TBL] [Abstract][Full Text] [Related]
28. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
Udelman HD; Udelman DL
J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
[TBL] [Abstract][Full Text] [Related]
29. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
[TBL] [Abstract][Full Text] [Related]
30. [Buspirone in the treatment of Generalized Anxiety Disorders].
Rzewuska M; Sobucka K
Psychiatr Pol; 1993; 27(5):545-61. PubMed ID: 8255947
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a music performance anxiety inventory for gifted adolescent musicians.
Osborne MS; Kenny DT
J Anxiety Disord; 2005; 19(7):725-51. PubMed ID: 16076421
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
van Laar MW; Volkerts ER; van Willigenburg AP
J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
[TBL] [Abstract][Full Text] [Related]
33. Treatment of music performance anxiety via psychological approaches: a review of selected CBT and psychodynamic literature.
Nagel JJ
Med Probl Perform Art; 2010 Dec; 25(4):141-8. PubMed ID: 21170476
[TBL] [Abstract][Full Text] [Related]
34. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
Arató M
J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
[No Abstract] [Full Text] [Related]
35. Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study.
Ratey J; Sovner R; Parks A; Rogentine K
J Clin Psychiatry; 1991 Apr; 52(4):159-62. PubMed ID: 2016248
[TBL] [Abstract][Full Text] [Related]
36. Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: a randomized clinical trial.
Hirshfeld-Becker DR; Masek B; Henin A; Blakely LR; Pollock-Wurman RA; McQuade J; DePetrillo L; Briesch J; Ollendick TH; Rosenbaum JF; Biederman J
J Consult Clin Psychol; 2010 Aug; 78(4):498-510. PubMed ID: 20658807
[TBL] [Abstract][Full Text] [Related]
37. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
[TBL] [Abstract][Full Text] [Related]
38. Strategies for treatment of generalized anxiety in the primary care setting.
Schweizer E; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 3():27-31; discussion 32-3. PubMed ID: 9133490
[TBL] [Abstract][Full Text] [Related]
39. Effect of beta blockade and beta stimulation on stage fright.
Brantigan CO; Brantigan TA; Joseph N
Am J Med; 1982 Jan; 72(1):88-94. PubMed ID: 6120650
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial of online versus clinic-based CBT for adolescent anxiety.
Spence SH; Donovan CL; March S; Gamble A; Anderson RE; Prosser S; Kenardy J
J Consult Clin Psychol; 2011 Oct; 79(5):629-42. PubMed ID: 21744945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
